2seventy bio, Inc. (NASDAQ:TSVT) Q3 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the 2seventy bio Third Quarter 2024 Earnings Conference Call. At this time all participants are in a listen-only mode.
2Seventy Bio Inc. (TSVT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Kynam Capital Derrick Tang | 5,953,825 | $17,504,246 | 1.03% | |
| 2. | Newtyn Management Noah Levy And Eugene Dozortsev | 2,534,836 | $7,452,418 | -1% | 1.29% |
| 3. | Baker Bros. Advisors Julian Baker And Felix Baker | 2,497,526 | $7,342,726 | 0.07% | |
| 4. | Casdin Capital Eli Casdin | 2,000,000 | $5,880,000 | 0.39% | |
| 5. | Eversept Partners Kamran Moghtaderi | 1,003,678 | $2,950,813 | +1% | 0.26% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.10 | 40,000 | Director | 2,000,000 | 2024-03-26 | Filing | |
| $5.07 | 330,000 | Director | 1,960,000 | 2024-03-25 | Filing | |
| $5.12 | 147,377 | Director | 1,630,000 | 2024-03-22 | Filing | |
| $4.90 | 300,000 | Director | 1,482,623 | 2024-03-21 | Filing | |
| $5.96 | 86,414 | Large Shareholder | 5,142,111 | 2023-08-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.79 | 1,838 | 150,527 | 2025-01-06 | Filing | ||
| $2.64 | 186 | 147,179 | 2025-01-07 | Filing | ||
| $2.79 | 5,000 | 147,365 | 2025-01-06 | Filing | ||
| $2.78 | 114 | 152,365 | 2025-01-06 | Filing | ||
| $2.94 | 1,000 | 152,479 | 2025-01-03 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,294,901 | $12,627,009 | 0% | |
| 2. | 4,222,654 | $12,414,602 | 0% | |
| 3. | 3,761,245 | $11,058,059 | 0% | |
| 4. | 2,917,884 | $8,578,581 | 0% | |
| 5. | 2,515,897 | $7,396,738 | 0% |
News See All
2seventy bio, Inc. (NASDAQ:TSVT) Q2 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the 2Seventy Bio Second Quarter 2024 Earnings Conference Call.
5 Penny Stocks with Insider Buying in 2024
Biotech company 2Seventy Bio Inc (NASDAQ:TSVT) saw heavy insider buying activity earlier this year when Casdin Capital, LLC, which has a director status at 2Seventy Bio Inc (NASDAQ:TSVT), bought 777...
2seventy bio, Inc. (NASDAQ:TSVT) Q1 2024 Earnings Call Transcript
2seventy bio, Inc. misses on earnings expectations. Reported EPS is $-0.81 EPS, expectations were $-0.72.
2seventy bio, Inc. (NASDAQ:TSVT) Q4 2023 Earnings Call Transcript
2seventy bio, Inc. beats earnings expectations. Reported EPS is $-1.11, expectations were $-1.22.
10 Stocks That Are About To Explode
The stock market has been quite tumultuous recently.
5 Oversold Small Cap Stocks To Buy
In this piece, we will take a look at the five oversold small cap stocks to buy.
Billionaire Hedge Funds
